Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche.
- Computacenter shares climb as much as 7.4%, reaching a record high, after the IT services company upgraded its profit before tax guidance for fiscal year 2026 once again, after doing so at its July trading update. The group also reported a revenue beat in the first half, driven by strong AI-related spend in the US.
- Rubis shares rise as much as 5.3% after the energy solutions firm boosted its Ebitda guidance for the full year.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche.
- Sandoz nudged up its mid-term guidance and set a goal of increasing the number of biosimilars in its portfolio to more than 100 by 2040, from 13 currently.
- Computacenter shares climb as much as 7.4%, reaching a record high, after the IT services company upgraded its profit before tax guidance for fiscal year 2026 once again, after doing so at its July trading update. The group also reported a revenue beat in the first half, driven by strong AI-related spend in the US.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Samsung's anticipated equity buyback is raising investor expectations that the Korean giant will buy up non‑voting preferred shares, narrowing a steep discount and setting an example for others.
- Asia PC maker shares drop after a report that Intel plans to raise personal computer CPU prices by another 10% as early as next month.
- An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of ageing, pointing to broader potential use of the treatment, according to its developer. Insilico’s shares jumped as much as 10% on Tuesday, the most since August 25th.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis shares fall as much as 3.9% after the Swiss pharma group’s potential blockbuster heart drug, pelacarsen, failed in a final-stage study. It’s the company’s second trial disappointment within a week, coming days after Novartis temporarily paused trials of an experimental cell therapy for autoimmune diseases.
- Nordex shares rise as much as 8.8%, the most in over four months, after being upgraded to buy at BofA Global Research. Analysts said they see “significant” earnings upgrades ahead following a period of underperformance from the wind turbine company.
- Soitec surges as much as 13%, the most since July 23, as the French chip material company lifted its revenue guidance for the second quarter of 2027, citing accelerating Photonics-SOI demand. The firm outlined expectations for full-year revenue in this segment to be 2.5x-3x the previous year’s level.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- The rally in stocks was led by chipmakers Samsung Electronics and SK Hynix on Monday, while foreign investors bought over a net 1.8 trillion won ($1.3 billion) of Korean stocks on the Kospi Index, extending inflows to a third session, according to exchange data.
- Largan shares fall more than 6% after August sales drop 16.2%
- The Ministry of Finance will issue special bonds to recapitalize eight financial institutions, including Industrial & Commercial Bank of China, Agricultural Bank of China and People’s Insurance Company (Group) of China , according to official announcements on Sunday. Tiwa Adebayo
See omnystudio.com/listener for privacy information.